Rivaroxaban Plus ASA in Embolic Stroke of Undetermined Source(AREST-ESUS)
Clinical trial NCT04273516 · COMPLETED
Trial details
- NCT number
- NCT04273516
- Sponsor
- Mazandaran University of Medical Sciences
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-22
- Primary completion
- 2023-04-10
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.